A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis

Eosinophilic esophagitis (EoE) is a chronic TH2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. Our aim was to utilize proteomics and primary cells a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2021-08, Vol.148 (2), p.486-494
Hauptverfasser: Hsieh, Lance Y., Chiang, Austin W.T., Duong, Loan D., Kuo, Chih-Chung, Dong, Stephanie X., Dohil, Ranjan, Kurten, Richard, Lewis, Nathan E., Aceves, Seema S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 494
container_issue 2
container_start_page 486
container_title Journal of allergy and clinical immunology
container_volume 148
creator Hsieh, Lance Y.
Chiang, Austin W.T.
Duong, Loan D.
Kuo, Chih-Chung
Dong, Stephanie X.
Dohil, Ranjan
Kurten, Richard
Lewis, Nathan E.
Aceves, Seema S.
description Eosinophilic esophagitis (EoE) is a chronic TH2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. Our aim was to utilize proteomics and primary cells as a novel approach to determine relevant profibrotic factors. We utilized primary esophageal EoE and normal fibroblasts, their derivative extracellular matrixes (ECMs), an approach of fibroblast culture on autologous versus nonautologous ECM, and proteomics to elucidate EoE ECM proteins that dysregulate cellular function. We cultured esophageal fibroblasts from normal esophagi and esophagi from patients with severe EoE on autologous versus nonautologous ECM. The EoE ECM proteome shifted normal esophageal fibroblast protein expression. Proteomic analysis demonstrated that thrombospondin-1 is detected only in the EoE ECM, is central in the EoE ECM protein-protein interactome, is found at significantly elevated levels in biopsy specimens from patients with active EoE, and induces fibroblast collagen I production. Fibroblasts from patients with EoE secrete a unique ECM proteome that reflects their in vivo state and induces collagen I and α-smooth muscle actin protein expression from normal fibroblasts. Thrombospondin-1 is a previously unappreciated profibrotic molecule in EoE. [Display omitted]
doi_str_mv 10.1016/j.jaci.2021.01.023
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8342625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674921001688</els_id><sourcerecordid>2487745942</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-d73647515db7551b42dd4fd0e4aecd9a71528049d323208c43c35c3739796c383</originalsourceid><addsrcrecordid>eNp9UUtrFTEYDaLYa_UPuJCAGzdzzXMyAyKU4gsKbnQdMsk3bYaZ5JpkLvXfN8Nti7oQPggh5zs5D4ReU7KnhLbvp_1krN8zwuie1GH8CdpR0qum7Zh8inaE9LRplejP0IucJ1LvvOufozPOpWxFK3foeIHX4H-tgCHHw425BjNjuC3JWJjndTYJL6Ykf4sPKRaIC2AzF0gZh5iWih39kOIwm1zwuAZbfAzYB5zhCKmSxuxD5fWztw8_-OLzS_RsNHOGV_fnOfr5-dOPy6_N1fcv3y4vrhorOl4ap3grlKTSDUpKOgjmnBgdAWHAut4oKllHRO8444x0VnDLpeWK96pvLe_4Ofp44j2swwLOQqjOZn1IfjHpt47G679fgr_R1_GoOy5Yy2QleHdPkGJNKRe9-LxFYwLENWsmOqWE7AWr0Lf_QKe4plDtaSal6qpCtiliJ5RNMecE46MYSvRWq570VqveatWkDuN16c2fNh5XHnqsgA8nANQwjx6SztZDsOB8Alu0i_5__Hfw8rZ4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557832028</pqid></control><display><type>article</type><title>A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis</title><source>Elsevier ScienceDirect Journals</source><creator>Hsieh, Lance Y. ; Chiang, Austin W.T. ; Duong, Loan D. ; Kuo, Chih-Chung ; Dong, Stephanie X. ; Dohil, Ranjan ; Kurten, Richard ; Lewis, Nathan E. ; Aceves, Seema S.</creator><creatorcontrib>Hsieh, Lance Y. ; Chiang, Austin W.T. ; Duong, Loan D. ; Kuo, Chih-Chung ; Dong, Stephanie X. ; Dohil, Ranjan ; Kurten, Richard ; Lewis, Nathan E. ; Aceves, Seema S.</creatorcontrib><description>Eosinophilic esophagitis (EoE) is a chronic TH2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. Our aim was to utilize proteomics and primary cells as a novel approach to determine relevant profibrotic factors. We utilized primary esophageal EoE and normal fibroblasts, their derivative extracellular matrixes (ECMs), an approach of fibroblast culture on autologous versus nonautologous ECM, and proteomics to elucidate EoE ECM proteins that dysregulate cellular function. We cultured esophageal fibroblasts from normal esophagi and esophagi from patients with severe EoE on autologous versus nonautologous ECM. The EoE ECM proteome shifted normal esophageal fibroblast protein expression. Proteomic analysis demonstrated that thrombospondin-1 is detected only in the EoE ECM, is central in the EoE ECM protein-protein interactome, is found at significantly elevated levels in biopsy specimens from patients with active EoE, and induces fibroblast collagen I production. Fibroblasts from patients with EoE secrete a unique ECM proteome that reflects their in vivo state and induces collagen I and α-smooth muscle actin protein expression from normal fibroblasts. Thrombospondin-1 is a previously unappreciated profibrotic molecule in EoE. [Display omitted]</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2021.01.023</identifier><identifier>PMID: 33556465</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Actin ; Annotations ; Autoimmune diseases ; Biopsy ; Cell culture ; Cloning ; Collagen (type I) ; Disease ; Endoplasmic reticulum ; Eosinophil ; Esophageal diseases ; Esophagitis ; Esophagus ; Extracellular matrix ; Fibroblasts ; Fibrosis ; Gastrointestinal diseases ; Gene expression ; interactome ; Leukocytes (eosinophilic) ; Lymphocytes T ; Proteins ; Proteomes ; Proteomics ; remodeling ; Smooth muscle ; Software ; Therapeutic targets ; Thrombospondin ; thrombospondin-1</subject><ispartof>Journal of allergy and clinical immunology, 2021-08, Vol.148 (2), p.486-494</ispartof><rights>2021 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright © 2021 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</rights><rights>2021. American Academy of Allergy, Asthma &amp; Immunology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-d73647515db7551b42dd4fd0e4aecd9a71528049d323208c43c35c3739796c383</citedby><cites>FETCH-LOGICAL-c483t-d73647515db7551b42dd4fd0e4aecd9a71528049d323208c43c35c3739796c383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674921001688$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33556465$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hsieh, Lance Y.</creatorcontrib><creatorcontrib>Chiang, Austin W.T.</creatorcontrib><creatorcontrib>Duong, Loan D.</creatorcontrib><creatorcontrib>Kuo, Chih-Chung</creatorcontrib><creatorcontrib>Dong, Stephanie X.</creatorcontrib><creatorcontrib>Dohil, Ranjan</creatorcontrib><creatorcontrib>Kurten, Richard</creatorcontrib><creatorcontrib>Lewis, Nathan E.</creatorcontrib><creatorcontrib>Aceves, Seema S.</creatorcontrib><title>A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Eosinophilic esophagitis (EoE) is a chronic TH2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. Our aim was to utilize proteomics and primary cells as a novel approach to determine relevant profibrotic factors. We utilized primary esophageal EoE and normal fibroblasts, their derivative extracellular matrixes (ECMs), an approach of fibroblast culture on autologous versus nonautologous ECM, and proteomics to elucidate EoE ECM proteins that dysregulate cellular function. We cultured esophageal fibroblasts from normal esophagi and esophagi from patients with severe EoE on autologous versus nonautologous ECM. The EoE ECM proteome shifted normal esophageal fibroblast protein expression. Proteomic analysis demonstrated that thrombospondin-1 is detected only in the EoE ECM, is central in the EoE ECM protein-protein interactome, is found at significantly elevated levels in biopsy specimens from patients with active EoE, and induces fibroblast collagen I production. Fibroblasts from patients with EoE secrete a unique ECM proteome that reflects their in vivo state and induces collagen I and α-smooth muscle actin protein expression from normal fibroblasts. Thrombospondin-1 is a previously unappreciated profibrotic molecule in EoE. [Display omitted]</description><subject>Actin</subject><subject>Annotations</subject><subject>Autoimmune diseases</subject><subject>Biopsy</subject><subject>Cell culture</subject><subject>Cloning</subject><subject>Collagen (type I)</subject><subject>Disease</subject><subject>Endoplasmic reticulum</subject><subject>Eosinophil</subject><subject>Esophageal diseases</subject><subject>Esophagitis</subject><subject>Esophagus</subject><subject>Extracellular matrix</subject><subject>Fibroblasts</subject><subject>Fibrosis</subject><subject>Gastrointestinal diseases</subject><subject>Gene expression</subject><subject>interactome</subject><subject>Leukocytes (eosinophilic)</subject><subject>Lymphocytes T</subject><subject>Proteins</subject><subject>Proteomes</subject><subject>Proteomics</subject><subject>remodeling</subject><subject>Smooth muscle</subject><subject>Software</subject><subject>Therapeutic targets</subject><subject>Thrombospondin</subject><subject>thrombospondin-1</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9UUtrFTEYDaLYa_UPuJCAGzdzzXMyAyKU4gsKbnQdMsk3bYaZ5JpkLvXfN8Nti7oQPggh5zs5D4ReU7KnhLbvp_1krN8zwuie1GH8CdpR0qum7Zh8inaE9LRplejP0IucJ1LvvOufozPOpWxFK3foeIHX4H-tgCHHw425BjNjuC3JWJjndTYJL6Ykf4sPKRaIC2AzF0gZh5iWih39kOIwm1zwuAZbfAzYB5zhCKmSxuxD5fWztw8_-OLzS_RsNHOGV_fnOfr5-dOPy6_N1fcv3y4vrhorOl4ap3grlKTSDUpKOgjmnBgdAWHAut4oKllHRO8444x0VnDLpeWK96pvLe_4Ofp44j2swwLOQqjOZn1IfjHpt47G679fgr_R1_GoOy5Yy2QleHdPkGJNKRe9-LxFYwLENWsmOqWE7AWr0Lf_QKe4plDtaSal6qpCtiliJ5RNMecE46MYSvRWq570VqveatWkDuN16c2fNh5XHnqsgA8nANQwjx6SztZDsOB8Alu0i_5__Hfw8rZ4</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Hsieh, Lance Y.</creator><creator>Chiang, Austin W.T.</creator><creator>Duong, Loan D.</creator><creator>Kuo, Chih-Chung</creator><creator>Dong, Stephanie X.</creator><creator>Dohil, Ranjan</creator><creator>Kurten, Richard</creator><creator>Lewis, Nathan E.</creator><creator>Aceves, Seema S.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210801</creationdate><title>A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis</title><author>Hsieh, Lance Y. ; Chiang, Austin W.T. ; Duong, Loan D. ; Kuo, Chih-Chung ; Dong, Stephanie X. ; Dohil, Ranjan ; Kurten, Richard ; Lewis, Nathan E. ; Aceves, Seema S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-d73647515db7551b42dd4fd0e4aecd9a71528049d323208c43c35c3739796c383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Actin</topic><topic>Annotations</topic><topic>Autoimmune diseases</topic><topic>Biopsy</topic><topic>Cell culture</topic><topic>Cloning</topic><topic>Collagen (type I)</topic><topic>Disease</topic><topic>Endoplasmic reticulum</topic><topic>Eosinophil</topic><topic>Esophageal diseases</topic><topic>Esophagitis</topic><topic>Esophagus</topic><topic>Extracellular matrix</topic><topic>Fibroblasts</topic><topic>Fibrosis</topic><topic>Gastrointestinal diseases</topic><topic>Gene expression</topic><topic>interactome</topic><topic>Leukocytes (eosinophilic)</topic><topic>Lymphocytes T</topic><topic>Proteins</topic><topic>Proteomes</topic><topic>Proteomics</topic><topic>remodeling</topic><topic>Smooth muscle</topic><topic>Software</topic><topic>Therapeutic targets</topic><topic>Thrombospondin</topic><topic>thrombospondin-1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hsieh, Lance Y.</creatorcontrib><creatorcontrib>Chiang, Austin W.T.</creatorcontrib><creatorcontrib>Duong, Loan D.</creatorcontrib><creatorcontrib>Kuo, Chih-Chung</creatorcontrib><creatorcontrib>Dong, Stephanie X.</creatorcontrib><creatorcontrib>Dohil, Ranjan</creatorcontrib><creatorcontrib>Kurten, Richard</creatorcontrib><creatorcontrib>Lewis, Nathan E.</creatorcontrib><creatorcontrib>Aceves, Seema S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hsieh, Lance Y.</au><au>Chiang, Austin W.T.</au><au>Duong, Loan D.</au><au>Kuo, Chih-Chung</au><au>Dong, Stephanie X.</au><au>Dohil, Ranjan</au><au>Kurten, Richard</au><au>Lewis, Nathan E.</au><au>Aceves, Seema S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>148</volume><issue>2</issue><spage>486</spage><epage>494</epage><pages>486-494</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Eosinophilic esophagitis (EoE) is a chronic TH2 disorder complicated by tissue fibrosis and loss of esophageal luminal patency. The fibrostenotic esophagus does not respond well to therapy, but profibrotic therapeutic targets are largely unclear. Our aim was to utilize proteomics and primary cells as a novel approach to determine relevant profibrotic factors. We utilized primary esophageal EoE and normal fibroblasts, their derivative extracellular matrixes (ECMs), an approach of fibroblast culture on autologous versus nonautologous ECM, and proteomics to elucidate EoE ECM proteins that dysregulate cellular function. We cultured esophageal fibroblasts from normal esophagi and esophagi from patients with severe EoE on autologous versus nonautologous ECM. The EoE ECM proteome shifted normal esophageal fibroblast protein expression. Proteomic analysis demonstrated that thrombospondin-1 is detected only in the EoE ECM, is central in the EoE ECM protein-protein interactome, is found at significantly elevated levels in biopsy specimens from patients with active EoE, and induces fibroblast collagen I production. Fibroblasts from patients with EoE secrete a unique ECM proteome that reflects their in vivo state and induces collagen I and α-smooth muscle actin protein expression from normal fibroblasts. Thrombospondin-1 is a previously unappreciated profibrotic molecule in EoE. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33556465</pmid><doi>10.1016/j.jaci.2021.01.023</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2021-08, Vol.148 (2), p.486-494
issn 0091-6749
1097-6825
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8342625
source Elsevier ScienceDirect Journals
subjects Actin
Annotations
Autoimmune diseases
Biopsy
Cell culture
Cloning
Collagen (type I)
Disease
Endoplasmic reticulum
Eosinophil
Esophageal diseases
Esophagitis
Esophagus
Extracellular matrix
Fibroblasts
Fibrosis
Gastrointestinal diseases
Gene expression
interactome
Leukocytes (eosinophilic)
Lymphocytes T
Proteins
Proteomes
Proteomics
remodeling
Smooth muscle
Software
Therapeutic targets
Thrombospondin
thrombospondin-1
title A unique esophageal extracellular matrix proteome alters normal fibroblast function in severe eosinophilic esophagitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A50%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20unique%20esophageal%20extracellular%20matrix%20proteome%20alters%20normal%20fibroblast%20function%20in%20severe%20eosinophilic%20esophagitis&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Hsieh,%20Lance%20Y.&rft.date=2021-08-01&rft.volume=148&rft.issue=2&rft.spage=486&rft.epage=494&rft.pages=486-494&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2021.01.023&rft_dat=%3Cproquest_pubme%3E2487745942%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557832028&rft_id=info:pmid/33556465&rft_els_id=S0091674921001688&rfr_iscdi=true